Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03386292
Other study ID # Monastir University
Secondary ID
Status Completed
Phase N/A
First received December 16, 2017
Last updated December 20, 2017
Start date June 16, 2017
Est. completion date September 30, 2017

Study information

Verified date December 2017
Source University of Monastir
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The publications on prevalence and risk factors of urinary and anal incontinence in women were performed mainly in Europe and America. Consequently, result extrapolation to Tunisian population may not be a good practice which justifies this study and demonstrates its importance.


Description:

A cross-sectional study will be conducted among female doctors and nurses randomly selected from 3 large hospitals in the center of Tunisia. The prevalence of urinary incontinence and anal incontinence will be measured using validated questionnaires.


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date September 30, 2017
Est. primary completion date September 30, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Professional seniority in the current service over than 6 months

- Subject has given his consent

Exclusion Criteria:

- Resident

- Intern

- An ongoing pregnancy

- A recent birth (less than 6 months)

- A psychiatric disease

- An acute or chronic kidney disease

- Neurological disease

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Tunisia Faculty of Medecine Monastir

Sponsors (1)

Lead Sponsor Collaborator
University of Monastir

Country where clinical trial is conducted

Tunisia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of urinary incontinence The participant will be asked to fill out the urinary symptom profile questionnaire (USP). This questionnaire contains 13 items to assess stress urinary incontinence, urge urinary incontinence and dysuria. Each question is scored from 0 to 3 providing a maximal score of 9, 21 and 9 for stress urinary incontinence, urge urinary incontinence and dysuria respectively. Women diagnosed with both stress and urge urinary incontinence by the USP were classified as having mixed urinary incontinence. 1 month
Primary Prevalence of anal incontinence The participant will be asked to fill out the anal incontinence Jorge and Wexner which contains five questions scored on a scale from zero (normal continence) to 20 (total incontinence). 1 month
Secondary Risk factors for urinary and anal incontinence 1 month
See also
  Status Clinical Trial Phase
Recruiting NCT06429254 - The Effect of Emotional Freedom Techniques on Pelvic Pain N/A
Completed NCT03896204 - Effect of Telephone-supported Joint Protection Technique Training N/A
Completed NCT06129279 - Effect of Emotional Freedom Technique on Symptoms in Dysmenorrhea N/A
Recruiting NCT05932563 - Study on the Epidemiological Characteristics of Female HPV Vaccination in China
Recruiting NCT05932576 - A Multicenter Cohort Study Assessing the Efficacy and Adverse Effects of HPV Vaccination in Chinese Women
Not yet recruiting NCT05325216 - Urinary Continence of Female POPRC and OIN N/A
Completed NCT05752110 - Effects of Subanesthetic Dose of Ketamine Given on Postoperative Mood in Patients Undergoing Fractional Curettage Phase 4